Production and Purification of Metal Radionuclides for PET Imaging of Disease

Solvent Extraction and Ion Exchange

Volumn 31, Issue 4, 2013, Pages 337-344

  Zeng, Dexing ^a   Anderson, Carolyn J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

molecular imaging; PET; production; radiometals; radionuclides

Indexed keywords

DISEASED TISSUES; HIGH SPECIFIC ACTIVITIES; PET IMAGING; POSITRON EMISSION TOMOGRAPHY (PET); RADIOMETALS;

MOLECULAR IMAGING; POLYETHYLENE TEREPHTHALATES; POSITRON EMISSION TOMOGRAPHY; PRODUCTION; PURIFICATION; ZIRCONIUM;

RADIOISOTOPES;

EID: 84880944085     PISSN: 07366299     EISSN: 15322262     Source Type: Journal    
DOI: 10.1080/07366299.2013.800402     Document Type: Review

References (39)

1. Tanaka, K. and Fukase, K. 2008. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics. Org. Biomol. Chem., 6: 815 - 828.
2. Ikotun, O. F. and Lapi, S. E. 2011. The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86. Future Med. Chem., 3: 599 - 621.
3. Wadas, T. J., Wong, E. H., Weisman, G. R. and Anderson, C. J. 2010. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem. Rev., 110: 2858 - 2902.
4. Rosenfeld, G. 1954. Studies of the metabolism of germanium. Arch. Biochem. Biophys., 48: 84 - 94.
5. 68Ga radiopharmaceutical chemistry. Curr. Top. Med. Chem., 10: 1633 - 1668.
6. Greene, M. W. and Tucker, W. D. 1961. An improved gallium-68 cow. Int. J. Appl. Radiat. Isot., 12: 62 - 63.
7. 68Ga. Int. J. Appl. Radiat. Isot., 25: 263 - 268.
8. Loc'h, C., Maziere, B. and Comar, D. 1980. A new generator for ionic gallium-68. J. Nucl. Med., 21: 171 - 173.
9. Zeng, D., Desai, A. V., Ranganathan, D., Wheeler, T. D., Kenis, P. J. and Reichert, D. E. 2013. Microfluidic radiolabeling of biomolecules with PET radiometals. Nucl. Med. Biol., 40: 42 - 51.
10. 68Ga]DOTATOC radiosynthesis. Appl. Radiat. Isot., 70: 2539 - 2544.
11. 68Ga-labeled peptides in tumor imaging. J. Nucl. Med., 46 (1): S172 - S178.
12. Wadas, T. J., Wong, E. H., Weisman, G. R. and Anderson, C. J. 2007. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr. Pharm. Des., 13: 3 - 16.
13. Zinn, K. R., Chaudhuri, T. R., Cheng, T. P., Morris, J. S. and Meyer, W. A. 1994. Production of no-carrier-added Cu-64 from zinc metal irradiated under boron shielding. Cancer., 73: 774 - 778.
14. Philpott, G. W., Schwarz, S. W., Anderson, C. J., Dehdashti, F., Connett, J. M., Zinn, K. R., Meares, C. F., Cutler, P. D., Welch, M. J., Siegel, B. A. and RadioimmunoPE, T. 1995. Detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J. Nucl. Med., 36: 1818 - 1824.
15. 64Cu at a small cyclotron. Appl. Radiat. Isot., 44: 575 - 580.
16. 64Cu using a biomedical cyclotron. Nucl. Med. Biol., 24: 35 - 43.
17. 64Cu using a 12 MeV cyclotron. Nucl. Med. Biol., 30: 535 - 539.
18. Kume, M., Carey, P. C., Gaehle, G., Madrid, E., Voller, T., Margenau, W., Welch, M.J. and Lapi, S.E. 2012. A semi-automated system for the routine production of copper-64. Appl. Radiat. Isot., 70: 1803 - 1806.
19. 67Ga waste products using anion exchange and low acid aqueous/organic mixtures. Radiochimica Acta., 75: 65 - 68.
20. 64Cu radioisotope production. J. Radioanal. Nucl. Chem., 277: 451 - 456.
21. 67Cu process. Appl. Radiat. Isot., 59: 343 - 351.
22. 44gSc from natural calcium. Appl. Radiat. Isot., 70: 1526 - 1530.
23. 89Zr: from radiochemistry to the clinic. Nucl. Med. Biol., 40: 3 - 14.
24. 89Zr. Radiochimica Acta., 97: 467 - 471.
25. 89Zr radiochemistry for positron emission tomography. Med. Chem., 7: 389 - 394.
26. 89Zr for antibody labeling and positron emission tomography. J. Labelled Compd. Radiopharm., 23: 1297
27. 89Zr, a potential PET antibody label. Appl. Radiat. Isot., 41: 789 - 790.
28. 89Zr for the labelling of antibodies with a positron emitter. Int. J. Appl. Radiat. Isot., 45: 1143 - 1147.
29. 89Zr-labeled monoclonal antibodies. J. Nucl. Med., 44: 1271 - 1281.
30. Holland, J. P., Sheh, Y. and Lewis, J. S. 2009. Standardized methods for the production of high specific-activity zirconium-89. Nucl. Med. Biol., 36: 729 - 739.
31. Oyen, W. J., Bodei, L., Giammarile, F., Maecke, H.R. and Tennvall, J. 2007. Luster, M; Brans, B. Targeted therapy in nuclear medicine--current status and future prospects. Ann. Oncol., 18: 1782 - 1792.
32. 86Y based PET radiopharmaceuticals: radiochemistry and biological applications. Med. Chem., 7: 380 - 388.
33. 90Y imaging?. Eur. J. Nucl. Med. Mol. Imaging., 38 (1): S57 - S68.
34. 86Y. Appl. Radiat. Isot., 64: 1521 - 1527.
35. 86Y using a small biomedical cyclotron. Nucl. Med. Biol., 32: 891 - 897.
36. 86Y for nuclear medical applications. Int. J. Appl. Radiat. Isot., 44: 667 - 681.
37. 86Y]yttrium. Eur. J. Nucl. Med. Mol. Imag., 38 (1): S4 - S9.
38. 86Y purification using a three-column system. Nucl. Med. Biol., 31: 297 - 301.
39. 86Y based on electrochemical separation. Appl. Radiat. Isot., 67: 523 - 529.